Drug
Aby 035
Aby 035: highest development phase Phase 2, developed by Acelyrin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Acelyrin
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABY-035 NCT04713072 | Phase 2 | Psoriatic Arthritis |
Latest
No recent events.
Follow Aby 035 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.